Urology Today.net

Site updated at Thursday, 12 May 2016

Common Urological Problems

Metastatic Prostate Cancer

Researchers Identify Molecular Predictor of Metastatic Prostate Cancer

Prostate tumors that carry a “signature” of four molecular markers have the potential to become dangerously metastatic if not treated aggressively, researchers at Dana-Farber Cancer Institute report in a study published online today by the journal Nature. The discovery lays the groundwork for the first gene-based test for determining whether a man’s prostate cancer… Researchers Identify Molecular Predictor of Metastatic Prostate Cancer   



Antifungal drug delays need for chemo in advanced prostate cancer

The oral antifungal drug itraconazole, most commonly used to treat nail fungus, may keep prostate cancer from worsening and delay the need for chemotherapy in men with advanced disease. Details of the finding, from a clinical trial led by Johns Hopkins experts, are scheduled for presentation on Saturday, June 4 at the 2011 American… Antifungal drug delays need for chemo in advanced prostate cancer   



For advanced prostate cancer, new drug slows disease

A new medication proved effective in slowing the spread of metastatic prostate cancer, while helping to maintain the quality of life, in patients with advanced disease. The phase 3 study was unblinded midway, allowing patients receiving the placebo to instead take the drug because of the favorable results.

The study is the first randomized… For advanced prostate cancer, new drug slows disease   



Noninvasive assay monitored treatment response in patients with metastatic prostate cancer

Deciding the ideal treatment for patients with metastatic prostate cancer that stops responding to initial therapy could be guided by certain analyses of cancer cells isolated from the patients’ blood, according to data published in Cancer Discovery, a journal of the American Association for Cancer Research.

“The growth and survival of prostate cancer cells… Noninvasive assay monitored treatment response in patients with metastatic prostate cancer   



The newest precision medicine tool: Prostate cancer organoids

Research led by investigators at Memorial Sloan Kettering Cancer Center has shown for the first time that organoids derived from human prostate cancer tumors can be grown in the laboratory, giving researchers an exciting new tool to test cancer drugs and personalize cancer treatment.

The researchers, whose results were published today in Cell, successfully… The newest precision medicine tool: Prostate cancer organoids   



jasn8 - risk of kidney failure1 - diabetic kidney1 - stenosis1 - stress incontinence5 - phosphorus1 - xanthine stones1 - chronic urinary tract infections1 - metabolic syndrome1 - lower urinary tract problems1 - hormone replacement1 - primary care1 - kidneys2 - mortality1 - benign prostate tissue1 - sexual intimacy1 - niaid1 - severe kyphoscoliosis1 - urinary excretion1 - prostate cancer cell1 - pelvic floor4 - stroke4 - obesity complications1 - cancer treatment3 - kidney damage7 - gametogenesis2 - etoposide-doxorubicin-cisplatin1 - nausea1 - pluripotent stem cells1 - genetic disease1 -